Showing 301 - 320 results of 225,031 for search '(( 5 ((mg decrease) OR (nn decrease)) ) OR ( 10 ((teer decrease) OR (a decrease)) ))', query time: 1.55s Refine Results
  1. 301

    OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

    Published 2019
    “…After 4 weeks, when the tumor size was approximately 100 mm<sup>3</sup> (T<sub>0</sub>) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”
  2. 302
  3. 303

    Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner by Khondoker Alam (1443499)

    Published 2017
    “…Compared with vehicle control treatment, bortezomib pretreatment significantly decreased the maximal transport velocity (V<sub>max</sub>) of OATP1B3-mediated transport of CCK-8 (92.25 ± 14.2 vs. 133.95 ± 15.5 pmol/mg protein/min) without affecting the affinity constant (K<sub>m</sub>) values. …”
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308
  9. 309

    Fig 5 - by Elizabeth A. Moore (18083377)

    Published 2024
    Subjects:
  10. 310
  11. 311

    Fig 10 - by Sana Khalid (132742)

    Published 2023
    Subjects:
  12. 312
  13. 313
  14. 314
  15. 315
  16. 316
  17. 317
  18. 318
  19. 319
  20. 320

    Transforming growth factor (TGF)-β1 induced a robust decrease in S-phase in non-cancer cell strains by Kimberly A Brown (26546)

    Published 2011
    “…Representative histograms are presented illustrating cells that had a robust decrease in S-phase (NMuMG), modest decrease in S-phase (EpH4), and no decrease in S-phase (MDA-MB-436) as a result of TGF-βtreatment. …”